{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T16:29:12Z","timestamp":1779208152699,"version":"3.51.4"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s11886-019-1227-4","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T07:02:13Z","timestamp":1573714933000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["How To Assess a Claudication and When To Intervene"],"prefix":"10.1007","volume":"21","author":[{"given":"Prio","family":"Hossain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damianos G.","family":"Kokkinidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehrin J.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,14]]},"reference":[{"issue":"9901","key":"1227_CR1","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","volume":"382","author":"FGR Fowkes","year":"2013","unstructured":"Fowkes FGR, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382(9901):1329\u201340. https:\/\/doi.org\/10.1016\/S0140-6736(13)61249-0.","journal-title":"Lancet."},{"issue":"1","key":"1227_CR2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.gheart.2013.12.008","volume":"9","author":"UKA Sampson","year":"2014","unstructured":"Sampson UKA, Fowkes FGR, McDermott MM, et al. Global and regional burden of death and disability from peripheral artery disease: 21 world regions, 1990 to 2010. Glob Heart. 2014;9(1):145\u2013158.e21. https:\/\/doi.org\/10.1016\/j.gheart.2013.12.008.","journal-title":"Glob Heart"},{"issue":"11","key":"1227_CR3","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/jama.286.11.1317","volume":"286","author":"AT Hirsch","year":"2001","unstructured":"Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286(11):1317\u201324. https:\/\/doi.org\/10.1001\/jama.286.11.1317.","journal-title":"JAMA."},{"issue":"7070","key":"1227_CR4","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1136\/bmj.313.7070.1440","volume":"313","author":"GC Leng","year":"2011","unstructured":"Leng GC, Fowkes FGR, Lee AJ, Dunbar J, Housley E, Ruckley CV. Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study. BMJ. 2011;313(7070):1440\u20134. https:\/\/doi.org\/10.1136\/bmj.313.7070.1440.","journal-title":"BMJ."},{"issue":"1","key":"1227_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1161\/circulationaha.110.003954","volume":"124","author":"RL Pande","year":"2011","unstructured":"Pande RL, Perlstein TS, Beckman JA, Creager MA. Secondary prevention and mortality in peripheral artery disease. Circulation. 2011;124(1):17\u201323. https:\/\/doi.org\/10.1161\/circulationaha.110.003954.","journal-title":"Circulation."},{"issue":"6","key":"1227_CR6","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1056\/NEJM199202063260605","volume":"326","author":"MH Criqui","year":"1992","unstructured":"Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326(6):381\u20136. https:\/\/doi.org\/10.1056\/NEJM199202063260605.","journal-title":"N Engl J Med"},{"issue":"12","key":"1227_CR7","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1016\/j.spinee.2013.06.021","volume":"13","author":"AJ Haig","year":"2013","unstructured":"Haig AJ, Park P, Henke PK, Yamakawa KSJ, Tomkins-Lane C, Valdivia J, et al. Reliability of the clinical examination in the diagnosis of neurogenic versus vascular claudication. Spine J. 2013;13(12):1826\u201334. https:\/\/doi.org\/10.1016\/j.spinee.2013.06.021.","journal-title":"Spine J"},{"issue":"1","key":"1227_CR8","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ajem.2007.06.026","volume":"26","author":"B Anderson","year":"2008","unstructured":"Anderson B, Kelly AM, Kerr D, Clooney M, Jolley D. Impact of patient and environmental factors on capillary refill time in adults. Am J Emerg Med. 2008;26(1):62\u20135. https:\/\/doi.org\/10.1016\/j.ajem.2007.06.026.","journal-title":"Am J Emerg Med"},{"issue":"5","key":"1227_CR9","doi-asserted-by":"publisher","first-page":"11294","DOI":"10.3390\/ijms160511294","volume":"16","author":"SM Krishna","year":"2015","unstructured":"Krishna SM, Moxon JV, Golledge J. A review of the pathophysiology and potential biomarkers for peripheral artery disease. Int J Mol Sci. 2015;16(5):11294\u2013322. https:\/\/doi.org\/10.3390\/ijms160511294.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1227_CR10","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1055\/s-0034-1393964","volume":"31","author":"MA Bailey","year":"2014","unstructured":"Bailey MA, Griffin KJ, Scott DJA. Clinical assessment of patients with peripheral arterial disease. Semin Interv Radiol. 2014;31(4):292\u20139. https:\/\/doi.org\/10.1055\/s-0034-1393964.","journal-title":"Semin Interv Radiol"},{"issue":"4","key":"1227_CR11","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1055\/s-0034-1393976","volume":"31","author":"RL Hardman","year":"2014","unstructured":"Hardman RL, Jazaeri O, Yi J, Smith M, Gupta R. Overview of classification systems in peripheral artery disease. Semin Interv Radiol. 2014;31(4):378\u201388. https:\/\/doi.org\/10.1055\/s-0034-1393976.","journal-title":"Semin Interv Radiol"},{"issue":"6","key":"1227_CR12","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1177\/0003319713488640","volume":"65","author":"M Maksimovic","year":"2014","unstructured":"Maksimovic M, Vlajinac H, Marinkovic J, Kocev N, Voskresenski T, Radak D. Health-related quality of life among patients with peripheral arterial disease. Angiology. 2014;65(6):501\u20136. https:\/\/doi.org\/10.1177\/0003319713488640.","journal-title":"Angiology."},{"issue":"4","key":"1227_CR13","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.jvs.2017.12.074","volume":"68","author":"AW Gardner","year":"2018","unstructured":"Gardner AW, Montgomery PS, Wang M, Xu C. Predictors of health-related quality of life in patients with symptomatic peripheral artery disease. J Vasc Surg. 2018;68(4):1126\u201334. https:\/\/doi.org\/10.1016\/j.jvs.2017.12.074.","journal-title":"J Vasc Surg"},{"issue":"2","key":"1227_CR14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jvn.2010.02.001","volume":"28","author":"L Egberg","year":"2010","unstructured":"Egberg L, Mattiasson A-C, Ljungstr\u00f6m K-G, Styrud J. Health-related quality of life in patients with peripheral arterial disease undergoing percutaneous transluminal angioplasty: a prospective one-year follow-up. J Vasc Nurs. 2010;28(2):72\u20137. https:\/\/doi.org\/10.1016\/j.jvn.2010.02.001.","journal-title":"J Vasc Nurs"},{"issue":"1","key":"1227_CR15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12963-016-0091-3","volume":"14","author":"S Yin","year":"2016","unstructured":"Yin S, Njai R, Barker L, Siegel PZ, Liao Y. Summarizing health-related quality of life (HRQOL): development and testing of a one-factor model. Popul Health Metrics. 2016;14(1):22. https:\/\/doi.org\/10.1186\/s12963-016-0091-3.","journal-title":"Popul Health Metrics"},{"key":"1227_CR16","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1161\/circulationaha.113.000502","volume":"128","author":"PW Wennberg","year":"2013","unstructured":"Wennberg PW. Approach to the patient with peripheral arterial disease. Circulation. 2013;128:2241\u201350. https:\/\/doi.org\/10.1161\/circulationaha.113.000502.","journal-title":"Circulation."},{"issue":"5","key":"1227_CR17","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1001\/jama.295.5.536","volume":"295","author":"NA Khan","year":"2006","unstructured":"Khan NA, Rahim SA, Anand SS, Simel DL, Panju A. Does the clinical examination predict lower extremity peripheral arterial disease? J Am Med Assoc. 2006;295(5):536\u201346. https:\/\/doi.org\/10.1001\/jama.295.5.536.","journal-title":"J Am Med Assoc"},{"key":"1227_CR18","doi-asserted-by":"publisher","first-page":"e686","DOI":"10.1161\/CIR.0000000000000471","volume":"135","author":"C Barrett","year":"2017","unstructured":"Barrett C, Barshes NR, Corriere MA, et al. 2016 AHA\/ACC Guideline on the Management of Patients with Lower Extremity Peripheral Artery Disease. Circulation. 2017;135:e686\u2013725. https:\/\/doi.org\/10.1161\/CIR.0000000000000471 The 2016 AHA\/ACC Guideline on the Management of Patients with Lower Extremity PAD summarizes the major recommendations involving PAD management for all types of medical practitioners. The guidelines are based on extensive literature review including meta-analyses, systematic reviews, and Cochrane reviews. They contain information regarding workup, diagnosis, medical management, surgical management, and prevention of PAD.","journal-title":"Circulation"},{"issue":"2","key":"1227_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1177\/1358863X17745371","volume":"23","author":"NK Itoga","year":"2018","unstructured":"Itoga NK, Minami HR, Chelvakumar M, Pearson K, Mell MM, Bendavid E, et al. Cost-effectiveness analysis of asymptomatic peripheral artery disease screening with the ABI test. Vasc Med. 2018;23(2):97\u2013106. https:\/\/doi.org\/10.1177\/1358863X17745371.","journal-title":"Vasc Med"},{"issue":"2","key":"1227_CR20","doi-asserted-by":"publisher","first-page":"e003860","DOI":"10.1161\/CIRCOUTCOMES.117.003860","volume":"11","author":"KG Smolderen","year":"2018","unstructured":"Smolderen KG, Gosch K, Patel M, Jones WS, Hirsch AT, Beltrame J, et al. PORTRAIT (Patient-Centered Outcomes Related to Treatment Practices in Peripheral Arterial Disease: Investigating Trajectories): overview of design and rationale of an international prospective peripheral arterial disease study. Circ Cardiovasc Qual Outcomes. 2018;11(2):e003860. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.117.003860.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"9","key":"1227_CR21","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.jcin.2015.04.021","volume":"8","author":"S Venkatachalam","year":"2015","unstructured":"Venkatachalam S, Lowry AM, Gornik HL, et al. The effect of post-exercise ankle-brachial index on lower extremity revascularization. JACC Cardiovasc Interv. 2015;8(9):1238\u201344. https:\/\/doi.org\/10.1016\/j.jcin.2015.04.021.","journal-title":"JACC Cardiovasc Interv"},{"issue":"3","key":"1227_CR22","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1055\/s-0033-1336830","volume":"22","author":"R Franz","year":"2013","unstructured":"Franz R, Jump M, Spalding MC, Jenkins J. Accuracy of duplex ultrasonography in estimation of severity of peripheral vascular disease. Int J Angiol. 2013;22(3):155\u20138. https:\/\/doi.org\/10.1055\/s-0033-1336830.","journal-title":"Int J Angiol"},{"issue":"20","key":"1227_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta11200","volume":"11","author":"R Collins","year":"2007","unstructured":"Collins R, Cranny G, Burch J, et al. A systematic review of duplex ultrasound, magnetic resonance angiography and computed tomography angiography for the diagnosis and assessment of symptomatic, lower limb peripheral arterial disease. Health Technol Assess. 2007;11(20):1\u2013184.","journal-title":"Health Technol Assess"},{"issue":"1","key":"1227_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/01.RVI.0000191361.02857.DE","volume":"17","author":"D Fleischmann","year":"2006","unstructured":"Fleischmann D, Hallett RL, Rubin GD. CT angiography of peripheral arterial disease. J Vasc Interv Radiol. 2006;17(1):3\u201326. https:\/\/doi.org\/10.1097\/01.RVI.0000191361.02857.DE.","journal-title":"J Vasc Interv Radiol"},{"issue":"4","key":"1227_CR25","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1001\/jama.301.4.415","volume":"301","author":"R Met","year":"2009","unstructured":"Met R, Bipat S, Legemate DA, Reekers JA, Koelemay MJW. Diagnostic performance of computed tomography angiography in peripheral arterial disease: a systematic review and meta-analysis. JAMA. 2009;301(4):415\u201324. https:\/\/doi.org\/10.1001\/jama.301.4.415.","journal-title":"JAMA."},{"issue":"6","key":"1227_CR26","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1161\/circimaging.111.970814","volume":"5","author":"AW Pollak","year":"2012","unstructured":"Pollak AW, Norton PT, Kramer CM. Multimodality imaging of lower extremity peripheral arterial disease. Circ Cardiovasc Imaging. 2012;5(6):797\u2013807. https:\/\/doi.org\/10.1161\/circimaging.111.970814.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"5","key":"1227_CR27","doi-asserted-by":"publisher","first-page":"325","DOI":"10.7326\/0003-4819-153-5-201009070-00007","volume":"153","author":"J Menke","year":"2010","unstructured":"Menke J, Larsen J. Meta-analysis: accuracy of contrast-enhanced magnetic resonance angiography for assessing steno-occlusions in peripheral arterial disease. Ann Intern Med. 2010;153(5):325\u201334. https:\/\/doi.org\/10.7326\/0003-4819-153-5-201009070-00007.","journal-title":"Ann Intern Med"},{"key":"1227_CR28","unstructured":"Dias-Neto M, Marques C, Sampaio S. Digital subtraction angiography or computed tomography angiography in the preoperative evaluation of lower limb peripheral artery disease\u2014a comparative analysis. Rev Port Cir Cardiotorac Vasc 24(3\u20134):174. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29701404. Accessed July 6, 2019."},{"issue":"2","key":"1227_CR29","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1148\/radiology.138.2.7455105","volume":"138","author":"SJ Hessel","year":"1981","unstructured":"Hessel SJ, Adams DF, Abrams HL. Complications of angiography. Radiology. 1981;138(2):273\u201381. https:\/\/doi.org\/10.1148\/radiology.138.2.7455105.","journal-title":"Radiology."},{"issue":"4","key":"1227_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.atherosclerosissup.2005.09.002","volume":"6","author":"S Goto","year":"2005","unstructured":"Goto S. Cilostazol: potential mechanism of action for antithrombotic effects accompanied by a low rate of bleeding. Atheroscler Suppl. 2005;6(4):3\u201311. https:\/\/doi.org\/10.1016\/j.atherosclerosissup.2005.09.002.","journal-title":"Atheroscler Suppl"},{"issue":"2","key":"1227_CR31","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jvs.2007.10.009","volume":"47","author":"WR Hiatt","year":"2008","unstructured":"Hiatt WR, Money SR, Brass EP. Long-term safety of cilostazol in patients with peripheral artery disease: the CASTLE study (cilostazol: a study in long-term effects). J Vasc Surg. 2008;47(2):330\u20136. https:\/\/doi.org\/10.1016\/j.jvs.2007.10.009.","journal-title":"J Vasc Surg"},{"issue":"12","key":"1227_CR32","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1002\/bjs.8895","volume":"99","author":"JW Stevens","year":"2012","unstructured":"Stevens JW, Simpson E, Harnan S, Squires H, Meng Y, Thomas S, et al. Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication. Br J Surg. 2012;99(12):1630\u20138. https:\/\/doi.org\/10.1002\/bjs.8895.","journal-title":"Br J Surg"},{"key":"1227_CR33","doi-asserted-by":"publisher","unstructured":"Bedenis R, Stewart M, Cleanthis M, Robless P, Mikhailidis DP, Stansby G. Cilostazol for intermittent claudication. Cochrane Database Syst Rev. 2014;(10):CD003748. https:\/\/doi.org\/10.1002\/14651858.CD003748.pub4.","DOI":"10.1002\/14651858.CD003748.pub4"},{"issue":"6","key":"1227_CR34","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/j.1875-9114.1984.tb03380.x","volume":"4","author":"Domingo M. Aviado","year":"1984","unstructured":"Aviado DM, Porter JM. Pentoxifylline: a new drug for the treatment of intermittent claudication. Mechanism of action, pharmacokinetics, clinical efficacy and adverse effects. Pharmacotherapy. 4(6):297\u2013307. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6393073. Accessed July 6, 2019.","journal-title":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"},{"key":"1227_CR35","doi-asserted-by":"publisher","unstructured":"Salhiyyah K, Forster R, Senanayake E, Abdel-Hadi M, Booth A, Michaels JA. Pentoxifylline for intermittent claudication. Cochrane Database Syst Rev. 2015;(1):CD005262. https:\/\/doi.org\/10.1002\/14651858.CD005262.pub3.","DOI":"10.1002\/14651858.CD005262.pub3"},{"issue":"1","key":"1227_CR36","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2015-000365","volume":"3","author":"MF McCarty","year":"2016","unstructured":"McCarty MF, O\u2019Keefe JH, DiNicolantonio JJ. Pentoxifylline for vascular health: a brief review of the literature. Open Hear. 2016;3(1):e000365. https:\/\/doi.org\/10.1136\/openhrt-2015-000365.","journal-title":"Open Hear"},{"key":"1227_CR37","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1161\/01.CIR.96.3.1031","volume":"96","author":"E Ernst","year":"1997","unstructured":"Ernst E. Chelation therapy for peripheral arterial occlusive disease: a systematic review. Circulation. 1997;96:1031\u20133. https:\/\/doi.org\/10.1161\/01.CIR.96.3.1031.","journal-title":"Circulation."},{"issue":"3","key":"1227_CR38","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1161\/01.cir.90.3.1194","volume":"90","author":"AM van Rij","year":"1994","unstructured":"van Rij AM, Solomon C, Packer SG, Hopkins WG. Chelation therapy for intermittent claudication. A double-blind, randomized, controlled trial. Circulation. 1994;90(3):1194\u20139. https:\/\/doi.org\/10.1161\/01.cir.90.3.1194.","journal-title":"Circulation."},{"issue":"4","key":"1227_CR39","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2165\/00002512-199608040-00005","volume":"8","author":"LB Barradell","year":"1996","unstructured":"Barradell LB, Brogden RN. Oral naftidrofuryl. A review of its pharmacology and therapeutic use in the management of peripheral occlusive arterial disease. Drugs Aging. 1996;8(4):299\u2013322. https:\/\/doi.org\/10.2165\/00002512-199608040-00005.","journal-title":"Drugs Aging"},{"issue":"Suppl3","key":"1227_CR40","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1097\/00005344-199406030-00008","volume":"23","author":"NF Wiernsperger","year":"1994","unstructured":"Wiernsperger NF. Serotonin, 5-HT2 receptors, and their blockade by naftidrofuryl: a targeted therapy of vascular diseases. J Cardiovasc Pharmacol. 1994;23(Suppl3):S37\u201343.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"15","key":"1227_CR41","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1093\/eurheartj\/ehv006","volume":"36","author":"H Reinecke","year":"2015","unstructured":"Reinecke H, Unrath M, Freisinger E, Bunzemeier H, Meyborg M, Luders F, et al. Peripheral arterial disease and critical limb ischaemia: still poor outcomes and lack of guideline adherence. Eur Heart J. 2015;36(15):932\u20138. https:\/\/doi.org\/10.1093\/eurheartj\/ehv006.","journal-title":"Eur Heart J"},{"issue":"3","key":"1227_CR42","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1177\/2047487313519344","volume":"22","author":"S Subherwal","year":"2015","unstructured":"Subherwal S, Patel MR, Kober L, Peterson ED, Bhatt DL, Gislason GH, et al. Peripheral artery disease is a coronary heart disease risk equivalent among both men and women: results from a nationwide study. Eur J Prev Cardiol. 2015;22(3):317\u201325. https:\/\/doi.org\/10.1177\/2047487313519344.","journal-title":"Eur J Prev Cardiol"},{"key":"1227_CR43","unstructured":"Victor, et al. \u201c2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in Collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries endorsed by: the European Stroke Organization (ESO) The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS).\u201d OUP Academic, Oxford University Press, 26 Aug. 2017, academic.oup.com\/eurheartj\/article\/39\/9\/763\/4095038"},{"issue":"6","key":"1227_CR44","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/j.jvs.2014.08.064","volume":"60","author":"EJ Armstrong","year":"2014","unstructured":"Armstrong EJ, Wu J, Singh GD, Dawson DL, Pevec WC, Amsterdam EA, et al. Smoking cessation is associated with decreased mortality and improved amputation-free survival among patients with symptomatic peripheral artery disease. J Vasc Surg. 2014;60(6):1565\u201371. https:\/\/doi.org\/10.1016\/j.jvs.2014.08.064.","journal-title":"J Vasc Surg"},{"key":"1227_CR45","unstructured":"Jonason T, Bergstr\u00f6m R. Cessation of smoking in patients with intermittent claudication. Effects on the risk of peripheral vascular complications, myocardial infarction and mortality. Acta Med Scand 1987;221(3):253\u2013260. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3591463. Accessed July 6, 2019."},{"issue":"20","key":"1227_CR46","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.010076","volume":"7","author":"KK Patel","year":"2018","unstructured":"Patel KK, Jones PG, Ellerbeck EF, Buchanan DM, Chan PS, Pacheco CM, et al. Underutilization of evidence-based smoking cessation support strategies despite high smoking addiction burden in peripheral artery disease specialty care: insights from the international PORTRAIT registry. J Am Heart Assoc. 2018;7(20):e010076. https:\/\/doi.org\/10.1161\/JAHA.118.010076.","journal-title":"J Am Heart Assoc"},{"key":"1227_CR47","doi-asserted-by":"publisher","unstructured":"Hartmann-Boyce J, Chepkin SC, Ye W, Bullen C, Lancaster T. Nicotine replacement therapy versus control for smoking cessation. Cochrane Database Syst Rev. 2018. https:\/\/doi.org\/10.1002\/14651858.CD000146.pub5.","DOI":"10.1002\/14651858.CD000146.pub5"},{"issue":"4","key":"1227_CR48","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.jvs.2016.10.121","volume":"65","author":"PP Goodney","year":"2017","unstructured":"Goodney PP, Spangler EL, Newhall K, Brooke BS, Schanzer A, Tan TW, et al. Feasibility and pilot efficacy of a brief smoking cessation intervention delivered by vascular surgeons in the Vascular Physician Offer and Report (VAPOR) Trial. J Vasc Surg. 2017;65(4):1152\u20131160.e2. https:\/\/doi.org\/10.1016\/j.jvs.2016.10.121.","journal-title":"J Vasc Surg"},{"issue":"13","key":"1227_CR49","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.010890","volume":"8","author":"TS Polonsky","year":"2019","unstructured":"Polonsky TS, Tian L, Zhang D, Bazzano LA, Criqui MH, Ferrucci L, et al. Associations of weight change with changes in calf muscle characteristics and functional decline in peripheral artery disease. J Am Heart Assoc. 2019;8(13):e010890. https:\/\/doi.org\/10.1161\/JAHA.118.010890.","journal-title":"J Am Heart Assoc"},{"issue":"13","key":"1227_CR50","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.013200","volume":"8","author":"DG Kokkinidis","year":"2019","unstructured":"Kokkinidis DG, Armstrong EJ, Giri J. Balancing weight loss and sarcopenia in elderly patients with peripheral artery disease. J Am Heart Assoc. 2019;8(13):e013200. https:\/\/doi.org\/10.1161\/JAHA.119.013200.","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"1227_CR51","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/nrcardio.2012.117","volume":"9","author":"DP Brostow","year":"2012","unstructured":"Brostow DP, Hirsch AT, Collins TC, Kurzer MS. The role of nutrition and body composition in peripheral arterial disease. Nat Rev Cardiol. 2012;9(11):634\u201343. https:\/\/doi.org\/10.1038\/nrcardio.2012.117.","journal-title":"Nat Rev Cardiol"},{"issue":"5","key":"1227_CR52","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1177\/1358863X15591088","volume":"20","author":"EV Nosova","year":"2015","unstructured":"Nosova EV, Bartel K, Chong KC, Alley HF, Conte MS, Owens CD, et al. Analysis of nutritional habits and intake of polyunsaturated fatty acids in veterans with peripheral arterial disease. Vasc Med. 2015;20(5):432\u20138. https:\/\/doi.org\/10.1177\/1358863X15591088.","journal-title":"Vasc Med"},{"key":"1227_CR53","doi-asserted-by":"publisher","unstructured":"Erratum: 2013. AHA\/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Circulation (2014) 129 (S76-S99)). Circulation. 2015. https:\/\/doi.org\/10.1161\/CIR.0000000000000155.","DOI":"10.1161\/CIR.0000000000000155"},{"issue":"7329","key":"1227_CR54","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","volume":"324","author":"A. T. Collaboration","year":"2002","unstructured":"Topic collections collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. 2009;324(7239):71\u201386. doi:https:\/\/doi.org\/10.1136\/bmj.324.7329.71","journal-title":"BMJ"},{"issue":"9038","key":"1227_CR55","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","volume":"348","author":"CAPRIE SC","year":"1996","unstructured":"CAPRIE SC. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348(9038):1329\u201339. https:\/\/doi.org\/10.1016\/S0140-6736(96)09457-3.","journal-title":"Lancet."},{"key":"1227_CR56","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1056\/nejmoa1611688","volume":"376","author":"WR Hiatt","year":"2016","unstructured":"Hiatt WR, Fowkes FGR, Heizer G, Berger JS, Baumgartner I, Held P, et al. Ticagrelor versus clopidogrel in symptomatic peripheral artery disease. N Engl J Med. 2016;376:32\u201340. https:\/\/doi.org\/10.1056\/nejmoa1611688.","journal-title":"N Engl J Med"},{"key":"1227_CR57","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1056\/nejmoa060989","volume":"354","author":"DL Bhatt","year":"2006","unstructured":"Bhatt DL, Fox KAA, Hacke W, Berger PB, Black HR, Boden WE, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med. 2006;354:1706\u201317. https:\/\/doi.org\/10.1056\/nejmoa060989.","journal-title":"N Engl J Med"},{"key":"1227_CR58","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1056\/NEJMoa1200933","volume":"366","author":"DA Morrow","year":"2012","unstructured":"Protocol for, Morrow DA, Braunwald E, Bonaca MP, et al. Vorapaxar in the secondary prevention of atherothrombotic events. NEJM. 2012;366:1404\u201313. https:\/\/doi.org\/10.1056\/NEJMoa1200933.","journal-title":"NEJM."},{"key":"1227_CR59","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1056\/nejmoa1709118","volume":"377","author":"P Widimsky","year":"2017","unstructured":"Widimsky P, Kakkar AK, St\u00f6rk S, et al. Rivaroxaban with or without aspirin in stable cardiovascular disease. N Engl J Med. 2017;377:1319\u201330. https:\/\/doi.org\/10.1056\/nejmoa1709118.","journal-title":"N Engl J Med"},{"issue":"5","key":"1227_CR60","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/j.jvs.2017.05.115","volume":"66","author":"K Stavroulakis","year":"2017","unstructured":"Stavroulakis K, Borowski M, Torsello G, Bisdas T, collaborators CRITISCH. Association between statin therapy and amputation-free survival in patients with critical limb ischemia in the CRITISCH registry. J Vasc Surg. 2017;66(5):1534\u201342. https:\/\/doi.org\/10.1016\/j.jvs.2017.05.115.","journal-title":"J Vasc Surg"},{"issue":"7","key":"1227_CR61","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.jacc.2013.09.073","volume":"63","author":"GG Westin","year":"2014","unstructured":"Westin GG, Armstrong EJ, Bang H, Yeo KK, Anderson D, Dawson DL, et al. Association between statin medications and mortality, major adverse cardiovascular event, and amputation-free survival in patients with critical limb ischemia. J Am Coll Cardiol. 2014;63(7):682\u201390. https:\/\/doi.org\/10.1016\/j.jacc.2013.09.073.","journal-title":"J Am Coll Cardiol"},{"issue":"9326","key":"1227_CR62","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","volume":"360","author":"Heart Protection Study Collaborative Group","year":"2002","unstructured":"Heart Protection Study Collaborative Group. MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet (London, England). 2002;360(9326):7\u201322. https:\/\/doi.org\/10.1016\/S0140-6736(02)09327-3.","journal-title":"Lancet (London, England)"},{"key":"1227_CR63","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1161\/JAHA.117.005699","volume":"6","author":"TR Foley","year":"2017","unstructured":"Foley TR, Singh GD, Kokkinidis DG, et al. High-intensity statin therapy is associated with improved survival in patients with peripheral artery disease. J Am Heart Assoc. 2017;6:7. https:\/\/doi.org\/10.1161\/JAHA.117.005699.","journal-title":"J Am Heart Assoc"},{"issue":"19","key":"1227_CR64","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1001\/jama.294.19.2437","volume":"294","author":"TR Pedersen","year":"2005","unstructured":"Pedersen TR, Faergeman O, Kastelein JJP, Olsson AG, Tikkanen MJ, Holme I, et al. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial. J Am Med Assoc. 2005;294(19):2437\u201345. https:\/\/doi.org\/10.1001\/jama.294.19.2437.","journal-title":"J Am Med Assoc"},{"key":"1227_CR65","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","volume":"129","author":"G De","year":"2014","unstructured":"De G, Eas ESC, De TG, et al. 2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Cons Salubr Gen. 2014;129:S1\u2013S45. https:\/\/doi.org\/10.1161\/01.cir.0000437738.63853.7a.","journal-title":"Cons Salubr Gen"},{"issue":"12","key":"1227_CR66","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1161\/01.CIR.0000090686.57897.F5","volume":"108","author":"ER Mohler","year":"2003","unstructured":"Mohler ER, Hiatt WR, Creager MA. Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease. Circulation. 2003;108(12):1481\u20136. https:\/\/doi.org\/10.1161\/01.CIR.0000090686.57897.F5.","journal-title":"Circulation."},{"issue":"3","key":"1227_CR67","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s11886-999-0029-5","volume":"1","author":"Scott Kinlay","year":"1999","unstructured":"Kinlay S, Plutzky J. Effect of lipid-lowering therapy on vasomotion and endothelial function. Curr Cardiol Rep 1999;1(3):238\u2013243. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10980848. Accessed July 6, 2019.","journal-title":"Current Cardiology Reports"},{"key":"1227_CR68","doi-asserted-by":"publisher","first-page":"CD000123","DOI":"10.1002\/14651858.CD000123.pub2","volume":"4","author":"PP Aung","year":"2007","unstructured":"Aung PP, Maxwell HG, Jepson RG, Price JF, Leng GC. Lipid-lowering for peripheral arterial disease of the lower limb. Cochrane Database Syst Rev. 2007;4:CD000123. https:\/\/doi.org\/10.1002\/14651858.CD000123.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"1227_CR69","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.117.032235","volume":"137","author":"MP Bonaca","year":"2018","unstructured":"Bonaca MP, Nault P, Giugliano RP, Keech AC, Pineda AL, Kanevsky E, et al. Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: insights from the FOURIER trial (further cardiovascular outcomes research with PCSK9 inhibition in subjects with elevated risk). Circulation. 2018;137(4):338\u201350. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.032235.","journal-title":"Circulation."},{"issue":"7258","key":"1227_CR70","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1136\/bmj.321.7258.412","volume":"321","author":"AI Adler","year":"2000","unstructured":"Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000;321(7258):412\u20139.","journal-title":"BMJ."},{"issue":"1","key":"1227_CR71","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3317\/jraas.2000.002","volume":"1","author":"P Sleight","year":"2000","unstructured":"Sleight P. The HOPE Study (Heart Outcomes Prevention Evaluation). J Renin-Angiotensin-Aldosterone Syst. 2000;1(1):18\u201320. https:\/\/doi.org\/10.3317\/jraas.2000.002.","journal-title":"J Renin-Angiotensin-Aldosterone Syst"},{"issue":"3","key":"1227_CR72","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1177\/1358863X15574321","volume":"20","author":"EJ Armstrong","year":"2015","unstructured":"Armstrong EJ, Chen DC, Singh GD, Amsterdam EA, Laird JR. Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use is associated with reduced major adverse cardiovascular events among patients with critical limb ischemia. Vasc Med. 2015;20(3):237\u201344. https:\/\/doi.org\/10.1177\/1358863X15574321.","journal-title":"Vasc Med"},{"key":"1227_CR73","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h5035","volume":"351","author":"M McCarthy","year":"2015","unstructured":"McCarthy M. Ramipril research papers are retracted over faked data. BMJ. 2015;351:h5035. https:\/\/doi.org\/10.1136\/bmj.h5035.","journal-title":"BMJ."},{"issue":"5","key":"1227_CR74","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1001\/jama.2012.216237","volume":"309","author":"AA Ahimastos","year":"2013","unstructured":"Ahimastos AA, Walker PJ, Askew C, Leicht A, Pappas E, Blombery P, et al. Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial. JAMA. 2013;309(5):453\u201360. https:\/\/doi.org\/10.1001\/jama.2012.216237.","journal-title":"JAMA."},{"issue":"7","key":"1227_CR75","doi-asserted-by":"publisher","first-page":"961","DOI":"10.4239\/wjd.v6.i7.961","volume":"6","author":"T Thiruvoipati","year":"2015","unstructured":"Thiruvoipati T, Kielhorn CE, Armstrong EJ. Peripheral artery disease in patients with diabetes: epidemiology, mechanisms, and outcomes. World J Diabetes. 2015;6(7):961\u20139. https:\/\/doi.org\/10.4239\/wjd.v6.i7.961.","journal-title":"World J Diabetes"},{"issue":"11","key":"1227_CR76","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.2337\/dc16-0850","volume":"39","author":"MI Spreen","year":"2016","unstructured":"Spreen MI, Gremmels H, Teraa M, Sprengers RW, Verhaar MC, Statius van Eps R, et al. Diabetes is associated with decreased limb survival in patients with critical limb ischemia: pooled data from two randomized controlled trials. Diabetes Care. 2016;39(11):2058\u201364. https:\/\/doi.org\/10.2337\/dc16-0850.","journal-title":"Diabetes Care"},{"issue":"1","key":"1227_CR77","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jvn.2014.12.001","volume":"33","author":"T Gorely","year":"2015","unstructured":"Gorely T, Crank H, Humphreys L, Nawaz S, Tew GA. \u201cStanding still in the street\u201d: experiences, knowledge and beliefs of patients with intermittent claudication\u2014a qualitative study. J Vasc Nurs. 2015;33(1):4\u20139. https:\/\/doi.org\/10.1016\/j.jvn.2014.12.001.","journal-title":"J Vasc Nurs"},{"issue":"3","key":"1227_CR78","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/HCR.0000000000000046","volume":"34","author":"MA Cunningham","year":"2014","unstructured":"Cunningham MA, Swanson V, Pappas E, O\u02bcCarroll RE, Holdsworth RJ. Illness beliefs and walking behavior after revascularization for intermittent claudication: a qualitative study. J Cardiopulm Rehabil Prev. 2014;34(3):195\u2013201. https:\/\/doi.org\/10.1097\/HCR.0000000000000046.","journal-title":"J Cardiopulm Rehabil Prev"},{"key":"1227_CR79","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1161\/circulationaha.109.881888","volume":"123","author":"NM Hamburg","year":"2011","unstructured":"Hamburg NM, Balady GJ. Exercise rehabilitation in peripheral artery disease. Circulation. 2011;123:87\u201397. https:\/\/doi.org\/10.1161\/circulationaha.109.881888.","journal-title":"Circulation."},{"issue":"7","key":"1227_CR80","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.jcin.2017.01.027","volume":"10","author":"A Pandey","year":"2017","unstructured":"Pandey A, Banerjee S, Ngo C, et al. Comparative efficacy of endovascular revascularization versus supervised exercise training in patients with intermittent claudication: meta-analysis of randomized controlled trials. JACC Cardiovasc Interv. 2017;10(7):712\u201324. https:\/\/doi.org\/10.1016\/j.jcin.2017.01.027 Findings from this study investigate the efficacy of different treatment methods for treating intermittent claudication\u2014in this case, operative management versus non-invasive management, which has been a longstanding area of interest for many practitioners. The findings suggest that the most effective treatment for IC involves a combination of exercise therapy and operative management, rather than either one alone.","journal-title":"JACC Cardiovasc Interv"},{"issue":"7","key":"1227_CR81","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0201095","volume":"13","author":"U Abaraogu","year":"2018","unstructured":"Abaraogu U, Ezenwankwo E, Dall P, Tew G, Stuart W, Brittenden J, et al. Barriers and enablers to walking in individuals with intermittent claudication: a systematic review to conceptualize a relevant and patient-centered program. PLoS One. 2018;13(7):e0201095. https:\/\/doi.org\/10.1371\/journal.pone.0201095.","journal-title":"PLoS One"},{"key":"1227_CR82","unstructured":"Jensen, TS., Chin, J., Ashby, L., Schafer, J., Dolan, D. Proposed national coverage determination for supervised exercise therapy (SET) for symptomatic peripheral artery disease (PAD) [Internet]. Baltimore (MD): Centers for Medicare and Medicaid Services; 2017 Mar 2. Available from: https:\/\/www.cms.gov\/medicare-coverage-database\/details\/nca-proposed-decisionmemo.aspx?NCAId=287"},{"issue":"5","key":"1227_CR83","doi-asserted-by":"publisher","first-page":"e001107","DOI":"10.1161\/JAHA.114.001107","volume":"3","author":"AW Gardner","year":"2014","unstructured":"Gardner AW, Parker DE, Montgomery PS, Blevins SM. Step-monitored home exercise improves ambulation, vascular function, and inflammation in symptomatic patients with peripheral artery disease: a randomized controlled trial. J Am Heart Assoc. 2014;3(5):e001107. https:\/\/doi.org\/10.1161\/JAHA.114.001107.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"1227_CR84","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1001\/jama.2013.7231","volume":"310","author":"MM McDermott","year":"2013","unstructured":"McDermott MM, Liu K, Guralnik JM, et al. Home-based walking exercise intervention in peripheral artery disease: a randomized clinical trial. JAMA. 2013;310(1):57\u201365. https:\/\/doi.org\/10.1001\/jama.2013.7231.","journal-title":"JAMA."},{"issue":"5","key":"1227_CR85","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1161\/CIRCULATIONAHA.110.963066","volume":"123","author":"AW Gardner","year":"2011","unstructured":"Gardner AW, Parker DE, Montgomery PS, Scott KJ, Blevins SM. Efficacy of quantified home-based exercise and supervised exercise in patients with intermittent claudication: a randomized controlled trial. Circulation. 2011;123(5):491\u20138. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.963066.","journal-title":"Circulation."},{"issue":"3","key":"1227_CR86","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000711","volume":"3","author":"MM McDermott","year":"2014","unstructured":"McDermott MM, Guralnik JM, Criqui MH, et al. Home-based walking exercise in peripheral artery disease: 12-month follow-up of the GOALS randomized trial. J Am Heart Assoc. 2014;3(3):e000711. https:\/\/doi.org\/10.1161\/JAHA.113.000711.","journal-title":"J Am Heart Assoc"},{"key":"1227_CR87","doi-asserted-by":"publisher","unstructured":"McDermott MM, Guralnik JM, Criqui MH, et al. Unsupervised exercise and mobility loss in peripheral artery disease: a randomized controlled trial. J Am Heart Assoc. 2015;4(5). https:\/\/doi.org\/10.1161\/JAHA.114.001659.","DOI":"10.1161\/JAHA.114.001659"},{"issue":"1","key":"1227_CR88","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jvs.2014.11.050","volume":"61","author":"J Nordanstig","year":"2015","unstructured":"Nordanstig J, Taft C, Hens\u00e4ter M. Improved quality of life after 1 year with an invasive versus a noninvasive treatment strategy in claudicants: one-year results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) trial. J Vasc Surg. 2015;61(1):280. https:\/\/doi.org\/10.1016\/j.jvs.2014.11.050.","journal-title":"J Vasc Surg"},{"issue":"12","key":"1227_CR89","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1042\/CS20080688","volume":"117","author":"G Tew","year":"2009","unstructured":"Tew G, Nawaz S, Zwierska I, Saxton JM. Limb-specific and cross-transfer effects of arm-crank exercise training in patients with symptomatic peripheral arterial disease. Clin Sci (Lond). 2009;117(12):405\u201313. https:\/\/doi.org\/10.1042\/CS20080688.","journal-title":"Clin Sci (Lond)"},{"issue":"6","key":"1227_CR90","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/j.jvs.2011.01.077","volume":"53","author":"UG Bronas","year":"2011","unstructured":"Bronas UG, Treat-Jacobson D, Leon AS. Comparison of the effect of upper body-ergometry aerobic training vs treadmill training on central cardiorespiratory improvement and walking distance in patients with claudication. J Vasc Surg. 2011;53(6):1557\u201364. https:\/\/doi.org\/10.1016\/j.jvs.2011.01.077.","journal-title":"J Vasc Surg"},{"issue":"7","key":"1227_CR91","doi-asserted-by":"publisher","first-page":"B302","DOI":"10.1093\/gerona\/56.7.b302","volume":"56","author":"MR McGuigan","year":"2001","unstructured":"McGuigan MR, Bronks R, Newton RU, et al. Resistance training in patients with peripheral arterial disease: effects on myosin isoforms, fiber type distribution, and capillary supply to skeletal muscle. J Gerontol A Biol Sci Med Sci. 2001;56(7):B302\u201310. https:\/\/doi.org\/10.1093\/gerona\/56.7.b302.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"1227_CR92","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/S0741-5214(05)80040-0","volume":"23","author":"Judith G. Regensteiner","year":"1996","unstructured":"Regensteiner JG, Steiner JF, Hiatt WR. Exercise training improves functional status in patients with peripheral arterial disease. J Vasc Surg 1996;23(1):104\u2013115. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8558725. Accessed July 6, 2019.","journal-title":"Journal of Vascular Surgery"},{"issue":"7","key":"1227_CR93","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.carrev.2015.06.006","volume":"16","author":"Z Fanari","year":"2015","unstructured":"Fanari Z, Weintraub WS. Cost-effectiveness of medical, endovascular and surgical management of peripheral vascular disease. Cardiovasc Revascularization Med. 2015;16(7):421\u20135. https:\/\/doi.org\/10.1016\/j.carrev.2015.06.006.","journal-title":"Cardiovasc Revascularization Med"},{"issue":"2","key":"1227_CR94","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1097\/SLA.0000000000001676","volume":"265","author":"JT Wiseman","year":"2017","unstructured":"Wiseman JT, Fernandes-Taylor S, Saha S, Havlena J, Rathouz PJ, Smith MA, et al. Endovascular versus open revascularization for peripheral arterial disease. Ann Surg. 2017;265(2):424\u201330. https:\/\/doi.org\/10.1097\/SLA.0000000000001676.","journal-title":"Ann Surg"},{"issue":"10","key":"1227_CR95","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s11886-015-0643-3","volume":"17","author":"T Kobayashi","year":"2015","unstructured":"Kobayashi T, Parikh SA, Giri J. Intermittent claudication due to peripheral artery disease: best modern medical and endovascular therapeutic approaches. Curr Cardiol Rep. 2015;17(10):86. https:\/\/doi.org\/10.1007\/s11886-015-0643-3.","journal-title":"Curr Cardiol Rep"},{"issue":"18","key":"1227_CR96","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1001\/jama.2015.14851","volume":"314","author":"F Fakhry","year":"2015","unstructured":"Fakhry F, Spronk S, van der Laan L, Wever JJ, Teijink JAW, Hoffmann WH, et al. Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial. JAMA. 2015;314(18):1936\u201344. https:\/\/doi.org\/10.1001\/jama.2015.14851.","journal-title":"JAMA."},{"issue":"6","key":"1227_CR97","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.ejvs.2008.10.007","volume":"36","author":"RM Greenhalgh","year":"2008","unstructured":"Greenhalgh RM, Belch JJF, Brown LC, Gaines PA, Gao L, Reise JA, et al. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease. Eur J Vasc Endovasc Surg. 2008;36(6):680\u20138. https:\/\/doi.org\/10.1016\/j.ejvs.2008.10.007.","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"1","key":"1227_CR98","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/bjs.7710","volume":"99","author":"FAK Mazari","year":"2012","unstructured":"Mazari FAK, Khan JA, Carradice D, Samuel N, Abdul Rahman MNA, Gulati S, et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. Br J Surg. 2012;99(1):39\u201348. https:\/\/doi.org\/10.1002\/bjs.7710.","journal-title":"Br J Surg"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-019-1227-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-019-1227-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-019-1227-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T00:35:53Z","timestamp":1605227753000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-019-1227-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":98,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["1227"],"URL":"https:\/\/doi.org\/10.1007\/s11886-019-1227-4","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"14 November 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Prio Hossain and Damianos G. Kokkinidis declare that they have no conflict of interest.Ehrin J. Armstrong is a consultant to Abbott Vascular, Boston Scientific, Cardiovascular Systems, Gore, Intact Vascular, Janssen, Medtronic, and Philips.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"138"}}